Sponsor pipeline

Lukas Biomedical Inc. clinical trial pipeline

Get alerts when Lukas Biomedical Inc.'s trials change

1 active trials 1 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-09-02
Primary completion pushed: 2026-12-31 → 2027-12-31
Completion pushed: 2027-06-30 → 2028-10-30
NCT05304481 Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma · Phase 2

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05304481 Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma Hepatocellular Carcinoma Recruiting 2026-09-01

Disease areas by active trials

Liver Cancer (1)

Get alerts when Lukas Biomedical Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free